ESMO 2016. LBA14_PR. FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole…
jwood@krftwrk.caNovember 9, 2016
ESMO 2016. Abstract 819P. Real world outcomes of patients with metastatic renal cell carcinoma (mRCC)…
jwood@krftwrk.caNovember 9, 2016
News in Lung Cancer ASCO 2015. Abstract 9001. Epidermal growth factor receptor (EGFR) genotyping of…
jwood@krftwrk.caJune 29, 2016
News in Prostate Cancer ASCO 2016. Abstract 5059. Effects of abiraterone (ABI) and enzalutamide (ENZA)…
jwood@krftwrk.caJune 29, 2016
Colorectal Cancer ASCO 2016. Abstract 3504. Impact of primary (1º) tumor location on overall survival…
jwood@krftwrk.caJune 29, 2016
Head and Neck Cancer ASCO 2016. Abstract 6008. BERIL-1: A phase II, placebo-controlled study of…
jwood@krftwrk.caJune 29, 2016
Metastatic Breast Cancer ASCO 2016. Abstract 525. Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal (PM)…
jwood@krftwrk.caJune 29, 2016
News in Chronic Lymphocytic Leukemia ASCO 2016. Abstract 7520. Outcomes with ibrutinib by line of…
jwood@krftwrk.caJune 29, 2016
ASCO GUCS 2016. Abstract 235. Observation of CNS events in real-world use of Enzalutamide (ENZ)…
jwood@krftwrk.caJanuary 27, 2016
